Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TIPRANAVIR vs TIVOZANIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TIPRANAVIR vs TIVOZANIB: Safety Overview

Metric TIPRANAVIR TIVOZANIB
Total FAERS Reports 403 1,395
Deaths Reported 14 135
Death Rate 3.5% 9.7%
Hospitalizations 261 291
Average Patient Age 48.2 yrs 64.4 yrs
% Female Patients 82.9% 28.3%
FDA Approval Date Jun 22, 2005 Mar 10, 2021
Manufacturer Boehringer Ingelheim Pharmaceuticals,... AVEO Pharmaceuticals, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription